Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia
      QxMD      Google Scholar   
Citation:
Proc Natl Acad Sci USA vol 114 (23) E4641-E4647
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
P50 CA140158, U10 CA180861, R01 CA102031, U10 CA077658, P30 CA086862, U10 CA180821, R35 CA197706, U10 CA180850, R01 CA135332, U10 CA180882, U24 CA196171, P30 CA016058, R35 CA197734  
Corr. Author:
Dimitrios Papaioannou 
Authors:
                                                 
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-10201, CALGB-10503, CALGB-10603, CALGB-19808, CALGB-20202, CALGB-8461, CALGB-8525, CALGB-8923, CALGB-9022, CALGB-9120, CALGB-9222, CALGB-9420, CALGB-9665, CALGB-9720
Phases:
1, 2, 3, N/A
Keywords:
EGFL7, acute myeloid leukemia, clinical outcome